Morpholino

MO5-esrra

ID
ZDB-MRPHLNO-160426-3
Name
MO5-esrra
Previous Names
None
Target
Sequence
5' - CAGAGCGTCGTTCTCTGGAAGACAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO5-esrra
Phenotype
Phenotype resulting from MO5-esrra
Phenotype of all Fish created by or utilizing MO5-esrra
Phenotype Fish Conditions Figures
whole organism cyc1 expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. S2 from Guh et al., 2016
whole organism atp5f1b expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. S2 from Guh et al., 2016
whole organism g6pd expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. S2 from Guh et al., 2016
proton transmembrane transport decreased occurrence, abnormal AB + MO5-esrra standard conditions Fig. 3 from Guh et al., 2016
whole organism atp6v1aa expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. 4 from Guh et al., 2016
vH ionocyte decreased amount, abnormal AB + MO5-esrra standard conditions Fig. 5 from Guh et al., 2016
vH ionocyte proton transmembrane transporter activity decreased efficacy, abnormal AB + MO5-esrra standard conditions Fig. 6 from Guh et al., 2016
whole organism slc4a1b expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. 4 from Guh et al., 2016
whole organism slc9a3.2 expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. 4 from Guh et al., 2016
whole organism cycsb expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. S2 from Guh et al., 2016
regulation of pH disrupted, abnormal AB + MO5-esrra acidic Fig. 3 from Guh et al., 2016
whole organism cs expression decreased amount, abnormal AB + MO5-esrra standard conditions Fig. S2 from Guh et al., 2016
proton transmembrane transport decreased occurrence, abnormal AB + MO5-esrra acidic Fig. 3 from Guh et al., 2016
Citations